SEC Form 4/A · accession 0000899243-18-027381
LogicBio Therapeutics, Inc. · LOGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Frederic Chereau
Officer — President, CEO · Director
Period of report
Oct 18, 2018
Accepted (ET)
Oct 24, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001664106
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1 | $10.00 | Oct 18, 2018 | A | 155,000 | A | — | Oct 17, 2028 | Common Stock | 155,000 | 155,000 | D |
Explanation of responses
- F1The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018.
- F2The Form 4, as originally filed, incorrectly reported the number of derivative securities acquired, the amount of underlying securities and the number of derivative securities beneficially owned. The Form 4, as amended by this Form 4/A, correctly reports such information.